	销售成本		日
Acadia Pharmaceuticals	USD 28.32M	3.52M	2026-06
Agios Pharmaceuticals	USD 1.32M	560K	2026-03
Alnylam Pharmaceuticals	USD 298.45M	87.33M	2026-06
BioCryst Pharmaceuticals	USD 3.84M	5.68M	2026-06
BioMarin Pharmaceutical	USD 276.29M	76.8M	2026-06
Insmed	USD 69.29M	19.79M	2026-06
Ionis Pharmaceuticals	USD 2.74M	261K	2026-06
Karyopharm Therapeutics	USD 1.34M	139K	2026-03
Kyowa Hakko Kirin	JPY 39.13B	6.13B	2026-06
MacroGenics	USD 9.53M	585K	2026-03
Moderna	USD 93M	862M	2026-06
Neurocrine Biosciences	USD 39.4M	25.6M	2026-06
PTC Therapeutics	USD 39.61M	23.31M	2026-03
Puma Biotechnology	USD 29.1M	18.44M	2024-09
Regeneron Pharmaceuticals	USD 576.5M	92.9M	2026-06
Sarepta Therapeutics	USD 150.1M	40.64M	2026-06
Ultragenyx Pharmaceutical	USD 30M	1000K	2026-03
Vertex Pharmaceuticals	USD 489.2M	96.4M	2026-06